20 studies found for:    Gd-DOTA
Show Display Options
Rank Status Study
1 Recruiting Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
Conditions: Renal Insufficiency, Chronic;   Kidney Diseases
Interventions: Drug: Calcium EDTA;   Drug: Gd-DOTA
2 Not yet recruiting Evaluation of Gadoterate in Patients With Decreased Kidney Function
Condition: Renal Dysfunction
Interventions: Drug: Gadoterate;   Other: No Gadoterate
3 Recruiting Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
Conditions: Adverse Reaction to Drug;   Allergic Reaction to Contrast Media
Intervention: Drug: Gadoteric Acid
4 Completed Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block
Conditions: Hip Fractures;   Anesthesia Local;   Pain, Perioperative
Intervention: Drug: Lidocaine-epinephrine added gadoterate meglumine
5 Completed Eovist vs. Dotarem Healthy Volunteer MRI
Condition: Transient Severe Arterial Phase Motion
Interventions: Drug: gadoxetate disodium;   Drug: gadoterate dimeglumine;   Drug: Saline
6 Completed Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block
Conditions: Hip Fractures;   Anesthesia, Local;   Pain, Postoperative
Interventions: Procedure: Ultrasound/MR image fusion guided lumbar plexus block (Shamrock);   Procedure: Ultrasound guided lumbar plexus block (Shamrock);   Drug: Lidocaine-epinephrine added gadoterate meglumine
7 Completed Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
Condition: Neoplastic CNS Lesions
Interventions: Drug: Gadovist® (Gadobutrol, BAY86-4875);   Drug: Dotarem
8 Completed
Has Results
Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
Condition: Peripheral Arterial Disease
Interventions: Drug: Dotarem;   Drug: Gadovist
9 Completed
Has Results
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Conditions: Diagnostic Self Evaluation;   Central Nervous System Diseases
Interventions: Drug: Dotarem (gadoterate meglumine);   Drug: Magnevist (gadopentetate dimeglumine)
10 Active, not recruiting DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
Condition: Hepatocellular Carcinoma
Intervention: Drug: Meglumine Gadoterate
11 Completed
Has Results
Renal Safety Evaluation After Dotarem®-Enhanced MRI
Condition: Renal Insufficiency
Interventions: Drug: Dotarem®-enhanced MRI;   Other: non-enhanced MRI
12 Active, not recruiting Crossover Comparison of MultiHance and Dotarem
Condition: Brain Disease
Interventions: Drug: Gadobenate;   Drug: Gadoterate
13 Terminated
Has Results
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition: Renal Artery Stenosis
Interventions: Drug: Gadoterate meglumine (Dotarem);   Other: Time of Flight Magnetic Resonance Angiography
14 Completed DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years
Condition: Magnetic Resonance Imaging
Intervention: Drug: DOTAREM
15 Completed
Has Results
Safety and Dialysability of Dotarem® in Dialysed Patients
Condition: End-stage Renal Failure
Intervention: Drug: Dotarem® IV injection at 0.1 mmol/kg
16 Completed
Has Results
Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition: Cerebral Arterial Diseases
Interventions: Drug: Dotarem;   Other: TOF MRA
17 Completed
Has Results
Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition: Cerebral Arterial Diseases
Interventions: Drug: Dotarem;   Other: TOF MRA
18 Terminated
Has Results
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
Condition: Renal Disease
Interventions: Drug: Dotarem;   Other: Time of Flight
19 Not yet recruiting Severe Sepsis in Children - IMPRESS-C
Conditions: Acute Kidney Injury;   Chronic Kidney Disease;   Hypertension
Interventions: Drug: Iodohippurate;   Procedure: 24 hour ambulatory Blood Pressure;   Procedure: Peripheral Arterial Tonometry;   Procedure: Pulse Wave Velocity;   Drug: Gadolinium
20 Not yet recruiting Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study
Conditions: Pulmonary Disease, Chronic Obstructive;   E-cigarettes
Interventions: Other: E-cigarette;   Other: Sham;   Drug: Hyperpolarized 3-Helium;   Drug: Gadolinium

Indicates status has not been verified in more than two years